Loading…

Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation

Long noncoding RNA cancer upregulated drug resistant (CUDR) is overexpressed in many tumors and promotes tumorigenesis. Herein, we demonstrate CUDR could enhance the human embryonic stem cells (ESC) differentiation into hepatocyte-like cells by reducing trimethylation on histone H3 twenty-seventh ly...

Full description

Saved in:
Bibliographic Details
Published in:Molecular therapy 2015-12, Vol.23 (12), p.1843-1853
Main Authors: Gui, Xin, Li, Haiyan, Li, Tianming, Pu, Hu, Lu, Dongdong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3
cites cdi_FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3
container_end_page 1853
container_issue 12
container_start_page 1843
container_title Molecular therapy
container_volume 23
creator Gui, Xin
Li, Haiyan
Li, Tianming
Pu, Hu
Lu, Dongdong
description Long noncoding RNA cancer upregulated drug resistant (CUDR) is overexpressed in many tumors and promotes tumorigenesis. Herein, we demonstrate CUDR could enhance the human embryonic stem cells (ESC) differentiation into hepatocyte-like cells by reducing trimethylation on histone H3 twenty-seventh lysine (H3K27me3). On the other hand, excessive CUDR triggers hepatocyte-like cells malignant transformation. Mechanistically, we identify CUDR causes highly upregulated in liver cancer (HULC) and β-catenin abnormal expression by inhibiting HULC promoter methylation and promoting β-catenin promoter-enhancer chromatin looping formation mediated by CUDR-ccctc-binding factor (CTCF) complex, which recruits more RNA polII and P300. Strikingly, HULC and β-catenin activity are crucial for CUDR oncogenic function. These findings provide the first demonstration that CUDR plays a positive potential role in liver cancer stem cell through the cascade of CUDR-HULC/CUDR-β-catenin signaling, and offer insights into a novel link between long noncoding RNA (lncRNA) and the epigenetic modification in cancer stem cells.
doi_str_mv 10.1038/mt.2015.166
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001616302015</els_id><sourcerecordid>1751486350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3</originalsourceid><addsrcrecordid>eNqNkc-KFDEQxhtR3HX15F1yFKTHpNP5Mxdh6dUdoV1hdM4hnVSPke5kTdIDvpYP4jOZZdZBwYOnfKn68VFVX1U9J3hFMJWv57xqMGErwvmD6pywhtUYN-3Dkyb8rHqS0teiCFvzx9VZw2krGCbnVeiD36Ob4E2wrqjtzSXqdldbtIX9MukMCW12fYe0t-jnj7orFe88ygFdhwNEjzbLrD3qXfmgTxlm1ME0oQ96cnuvfUZXbhwhgs9OZxf80-rRqKcEz-7fi2r37u3nblP3H6_fd5d9bRjFuTZWY8EpBWphDZhaOTK5HkDztZDCNBIPVlvCNWFDKwaQDAZJG2GtHvXIgF5Ub46-t8swgzVlgKgndRvdrON3FbRTf3e8-6L24aBaUc6EZTF4eW8Qw7cFUlazS6bspj2EJSkiBJWUS9b8B8pIKzlluKCvjqiJIaUI42kigtVdmmrO6i5NVdIs9Is_lzixv-MrADsCUE55cBBVMg68AesimKxscP80_gUP864E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751486350</pqid></control><display><type>article</type><title>Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation</title><source>PubMed Central</source><creator>Gui, Xin ; Li, Haiyan ; Li, Tianming ; Pu, Hu ; Lu, Dongdong</creator><creatorcontrib>Gui, Xin ; Li, Haiyan ; Li, Tianming ; Pu, Hu ; Lu, Dongdong</creatorcontrib><description>Long noncoding RNA cancer upregulated drug resistant (CUDR) is overexpressed in many tumors and promotes tumorigenesis. Herein, we demonstrate CUDR could enhance the human embryonic stem cells (ESC) differentiation into hepatocyte-like cells by reducing trimethylation on histone H3 twenty-seventh lysine (H3K27me3). On the other hand, excessive CUDR triggers hepatocyte-like cells malignant transformation. Mechanistically, we identify CUDR causes highly upregulated in liver cancer (HULC) and β-catenin abnormal expression by inhibiting HULC promoter methylation and promoting β-catenin promoter-enhancer chromatin looping formation mediated by CUDR-ccctc-binding factor (CTCF) complex, which recruits more RNA polII and P300. Strikingly, HULC and β-catenin activity are crucial for CUDR oncogenic function. These findings provide the first demonstration that CUDR plays a positive potential role in liver cancer stem cell through the cascade of CUDR-HULC/CUDR-β-catenin signaling, and offer insights into a novel link between long noncoding RNA (lncRNA) and the epigenetic modification in cancer stem cells.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1038/mt.2015.166</identifier><identifier>PMID: 26347501</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>beta Catenin - genetics ; beta Catenin - metabolism ; CCCTC-Binding Factor ; Cell Differentiation ; Cell Line, Tumor ; Cell Transformation, Neoplastic - genetics ; Embryonic Stem Cells - cytology ; Embryonic Stem Cells - metabolism ; Gene Expression Regulation, Neoplastic ; Hepatocytes - cytology ; Hepatocytes - metabolism ; Histones - genetics ; Histones - metabolism ; Humans ; Liver - cytology ; Liver - metabolism ; Liver Neoplasms - therapy ; Original ; Promoter Regions, Genetic ; Repressor Proteins - genetics ; Repressor Proteins - metabolism ; RNA, Long Noncoding - genetics ; Signal Transduction ; Up-Regulation</subject><ispartof>Molecular therapy, 2015-12, Vol.23 (12), p.1843-1853</ispartof><rights>2015 American Society of Gene &amp; Cell Therapy</rights><rights>Copyright © 2015 American Society of Gene &amp; Cell Therapy 2015 American Society of Gene &amp; Cell Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3</citedby><cites>FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700108/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700108/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26347501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gui, Xin</creatorcontrib><creatorcontrib>Li, Haiyan</creatorcontrib><creatorcontrib>Li, Tianming</creatorcontrib><creatorcontrib>Pu, Hu</creatorcontrib><creatorcontrib>Lu, Dongdong</creatorcontrib><title>Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><description>Long noncoding RNA cancer upregulated drug resistant (CUDR) is overexpressed in many tumors and promotes tumorigenesis. Herein, we demonstrate CUDR could enhance the human embryonic stem cells (ESC) differentiation into hepatocyte-like cells by reducing trimethylation on histone H3 twenty-seventh lysine (H3K27me3). On the other hand, excessive CUDR triggers hepatocyte-like cells malignant transformation. Mechanistically, we identify CUDR causes highly upregulated in liver cancer (HULC) and β-catenin abnormal expression by inhibiting HULC promoter methylation and promoting β-catenin promoter-enhancer chromatin looping formation mediated by CUDR-ccctc-binding factor (CTCF) complex, which recruits more RNA polII and P300. Strikingly, HULC and β-catenin activity are crucial for CUDR oncogenic function. These findings provide the first demonstration that CUDR plays a positive potential role in liver cancer stem cell through the cascade of CUDR-HULC/CUDR-β-catenin signaling, and offer insights into a novel link between long noncoding RNA (lncRNA) and the epigenetic modification in cancer stem cells.</description><subject>beta Catenin - genetics</subject><subject>beta Catenin - metabolism</subject><subject>CCCTC-Binding Factor</subject><subject>Cell Differentiation</subject><subject>Cell Line, Tumor</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Embryonic Stem Cells - cytology</subject><subject>Embryonic Stem Cells - metabolism</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hepatocytes - cytology</subject><subject>Hepatocytes - metabolism</subject><subject>Histones - genetics</subject><subject>Histones - metabolism</subject><subject>Humans</subject><subject>Liver - cytology</subject><subject>Liver - metabolism</subject><subject>Liver Neoplasms - therapy</subject><subject>Original</subject><subject>Promoter Regions, Genetic</subject><subject>Repressor Proteins - genetics</subject><subject>Repressor Proteins - metabolism</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Signal Transduction</subject><subject>Up-Regulation</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkc-KFDEQxhtR3HX15F1yFKTHpNP5Mxdh6dUdoV1hdM4hnVSPke5kTdIDvpYP4jOZZdZBwYOnfKn68VFVX1U9J3hFMJWv57xqMGErwvmD6pywhtUYN-3Dkyb8rHqS0teiCFvzx9VZw2krGCbnVeiD36Ob4E2wrqjtzSXqdldbtIX9MukMCW12fYe0t-jnj7orFe88ygFdhwNEjzbLrD3qXfmgTxlm1ME0oQ96cnuvfUZXbhwhgs9OZxf80-rRqKcEz-7fi2r37u3nblP3H6_fd5d9bRjFuTZWY8EpBWphDZhaOTK5HkDztZDCNBIPVlvCNWFDKwaQDAZJG2GtHvXIgF5Ub46-t8swgzVlgKgndRvdrON3FbRTf3e8-6L24aBaUc6EZTF4eW8Qw7cFUlazS6bspj2EJSkiBJWUS9b8B8pIKzlluKCvjqiJIaUI42kigtVdmmrO6i5NVdIs9Is_lzixv-MrADsCUE55cBBVMg68AesimKxscP80_gUP864E</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>Gui, Xin</creator><creator>Li, Haiyan</creator><creator>Li, Tianming</creator><creator>Pu, Hu</creator><creator>Lu, Dongdong</creator><general>Elsevier Inc</general><general>Nature Publishing Group</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20151201</creationdate><title>Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation</title><author>Gui, Xin ; Li, Haiyan ; Li, Tianming ; Pu, Hu ; Lu, Dongdong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>beta Catenin - genetics</topic><topic>beta Catenin - metabolism</topic><topic>CCCTC-Binding Factor</topic><topic>Cell Differentiation</topic><topic>Cell Line, Tumor</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Embryonic Stem Cells - cytology</topic><topic>Embryonic Stem Cells - metabolism</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hepatocytes - cytology</topic><topic>Hepatocytes - metabolism</topic><topic>Histones - genetics</topic><topic>Histones - metabolism</topic><topic>Humans</topic><topic>Liver - cytology</topic><topic>Liver - metabolism</topic><topic>Liver Neoplasms - therapy</topic><topic>Original</topic><topic>Promoter Regions, Genetic</topic><topic>Repressor Proteins - genetics</topic><topic>Repressor Proteins - metabolism</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Signal Transduction</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gui, Xin</creatorcontrib><creatorcontrib>Li, Haiyan</creatorcontrib><creatorcontrib>Li, Tianming</creatorcontrib><creatorcontrib>Pu, Hu</creatorcontrib><creatorcontrib>Lu, Dongdong</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gui, Xin</au><au>Li, Haiyan</au><au>Li, Tianming</au><au>Pu, Hu</au><au>Lu, Dongdong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>23</volume><issue>12</issue><spage>1843</spage><epage>1853</epage><pages>1843-1853</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>Long noncoding RNA cancer upregulated drug resistant (CUDR) is overexpressed in many tumors and promotes tumorigenesis. Herein, we demonstrate CUDR could enhance the human embryonic stem cells (ESC) differentiation into hepatocyte-like cells by reducing trimethylation on histone H3 twenty-seventh lysine (H3K27me3). On the other hand, excessive CUDR triggers hepatocyte-like cells malignant transformation. Mechanistically, we identify CUDR causes highly upregulated in liver cancer (HULC) and β-catenin abnormal expression by inhibiting HULC promoter methylation and promoting β-catenin promoter-enhancer chromatin looping formation mediated by CUDR-ccctc-binding factor (CTCF) complex, which recruits more RNA polII and P300. Strikingly, HULC and β-catenin activity are crucial for CUDR oncogenic function. These findings provide the first demonstration that CUDR plays a positive potential role in liver cancer stem cell through the cascade of CUDR-HULC/CUDR-β-catenin signaling, and offer insights into a novel link between long noncoding RNA (lncRNA) and the epigenetic modification in cancer stem cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26347501</pmid><doi>10.1038/mt.2015.166</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-0016
ispartof Molecular therapy, 2015-12, Vol.23 (12), p.1843-1853
issn 1525-0016
1525-0024
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700108
source PubMed Central
subjects beta Catenin - genetics
beta Catenin - metabolism
CCCTC-Binding Factor
Cell Differentiation
Cell Line, Tumor
Cell Transformation, Neoplastic - genetics
Embryonic Stem Cells - cytology
Embryonic Stem Cells - metabolism
Gene Expression Regulation, Neoplastic
Hepatocytes - cytology
Hepatocytes - metabolism
Histones - genetics
Histones - metabolism
Humans
Liver - cytology
Liver - metabolism
Liver Neoplasms - therapy
Original
Promoter Regions, Genetic
Repressor Proteins - genetics
Repressor Proteins - metabolism
RNA, Long Noncoding - genetics
Signal Transduction
Up-Regulation
title Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A06%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%20Noncoding%20RNA%20CUDR%20Regulates%20HULC%20and%20%CE%B2-Catenin%20to%20Govern%20Human%20Liver%20Stem%20Cell%20Malignant%20Differentiation&rft.jtitle=Molecular%20therapy&rft.au=Gui,%20Xin&rft.date=2015-12-01&rft.volume=23&rft.issue=12&rft.spage=1843&rft.epage=1853&rft.pages=1843-1853&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1038/mt.2015.166&rft_dat=%3Cproquest_pubme%3E1751486350%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c530t-cda07633e3de9e03d8f589bea69787c280bdad16a15b47be85eb8327ddafaf5e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1751486350&rft_id=info:pmid/26347501&rfr_iscdi=true